Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
8-Nov-2021 | |||
KEYNOTE-495/KeyImPaCT: Interim Analysis of a Randomized, Biomarker-Directed, ProgramsPhase 2 Trial of Pembrolizumab-Based Combination Therapy for Non–Small Cell Lung Cancer Proceeding/Conference:The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021) | 2021 |